company background image
511509 logo

Vivo Bio Tech BSE:511509 Stock Report

Last Price

₹37.69

Market Cap

₹561.7m

7D

1.4%

1Y

38.6%

Updated

23 Jul, 2024

Data

Company Financials

Vivo Bio Tech Limited

BSE:511509 Stock Report

Market Cap: ₹561.7m

511509 Stock Overview

Provides drug development and discovery services to pharmaceutical and biotech companies worldwide.

511509 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health3/6
Dividends0/6

Vivo Bio Tech Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Vivo Bio Tech
Historical stock prices
Current Share Price₹37.69
52 Week High₹56.00
52 Week Low₹26.51
Beta0.77
11 Month Change-6.15%
3 Month Change-17.29%
1 Year Change38.62%
33 Year Change-52.89%
5 Year Change29.52%
Change since IPO-47.06%

Recent News & Updates

Recent updates

Shareholder Returns

511509IN Life SciencesIN Market
7D1.4%-0.7%-2.0%
1Y38.6%16.2%42.8%

Return vs Industry: 511509 exceeded the Indian Life Sciences industry which returned 17% over the past year.

Return vs Market: 511509 underperformed the Indian Market which returned 43.8% over the past year.

Price Volatility

Is 511509's price volatile compared to industry and market?
511509 volatility
511509 Average Weekly Movement3.7%
Life Sciences Industry Average Movement5.4%
Market Average Movement6.4%
10% most volatile stocks in IN Market9.7%
10% least volatile stocks in IN Market4.2%

Stable Share Price: 511509 has not had significant price volatility in the past 3 months.

Volatility Over Time: 511509's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1987150Alangudi Sankaranarayananwww.vivobio.com

Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vitro, in vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxic kinetic studies, genotoxicity screening, analytical services, etc. It also supplies SPF lab animals; and rodent models, cyagen biosciences, custom rodent models, and stem cell products, as well as lab animal diets. In addition, the company provides regulatory and non-regulatory IND enabling preclinical development services; screening and evaluating molecules for various pharmacological and therapeutic properties; and design and development of syngeneic / xenograft models for evaluation of anti-cancer agents.

Vivo Bio Tech Limited Fundamentals Summary

How do Vivo Bio Tech's earnings and revenue compare to its market cap?
511509 fundamental statistics
Market cap₹561.71m
Earnings (TTM)₹25.26m
Revenue (TTM)₹454.51m

22.2x

P/E Ratio

1.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
511509 income statement (TTM)
Revenue₹454.51m
Cost of Revenue₹38.50m
Gross Profit₹416.02m
Other Expenses₹390.75m
Earnings₹25.26m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.70
Gross Margin91.53%
Net Profit Margin5.56%
Debt/Equity Ratio134.3%

How did 511509 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.